Back
The Bank of N.T. Butterfield & Son Ltd. Vs. Sarepta Therapeutics, Inc. Industry Stock Comparison
Buy
73
NTB
The Bank of N.T. Butterfield & Son Ltd.
Last Price:
$50.51
Seasonality Move:
3.94%
Sell
44
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$21.55
Seasonality Move:
6.08%
Buy
73
The Bank of N.T. Butterfield & Son Ltd. (NTB)
is a Buy
Is The Bank of N.T. Butterfield & Son Ltd. a Buy, Sell or Hold?
-
The current The Bank of N.T. Butterfield & Son Ltd. [NTB] share price is $50.52. The Score for NTB is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
NTB is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $22.12. The Score for SRPT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NTB Stock Price Chart
What is The Bank of N.T. Butterfield & Son Ltd.'s stock price today?
-
The The Bank of N.T. Butterfield & Son Ltd. share price today is $50.52The current trend is moderately bullish and NTB is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $22.12Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight selling pressure.
NTB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.26 | Buy |
| Relative Strength Index (14 RSI): | 64.74 | Buy |
| Chaikin Money Flow: | -44428 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.06 - 51.2) | Buy |
| Bollinger Bands (100): | (42.73 - 48.15) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.95 | Buy |
| Relative Strength Index (14 RSI): | 56.1 | Buy |
| Chaikin Money Flow: | -75967 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.51 - 22.53) | Buy |
| Bollinger Bands (100): | (17.83 - 22.33) | Buy |
NTB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.07 | Sell |
| 20-day SMA: | 49.89 | Buy |
| 50-day SMA: | 46.72 | Buy |
| 200-day SMA: | 43.62 | Buy |
| 8-day EMA: | 50.77 | Sell |
| 20-day EMA: | 49.8 | Buy |
| 50-day EMA: | 47.69 | Buy |
| 200-day EMA: | 43.9 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.56 | Buy |
| 20-day SMA: | 21.6 | Buy |
| 50-day SMA: | 20.78 | Buy |
| 200-day SMA: | 30.48 | Sell |
| 8-day EMA: | 17.99 | Buy |
| 20-day EMA: | 10.86 | Buy |
| 50-day EMA: | 5.25 | Buy |
| 200-day EMA: | 1.45 | Buy |
The Bank of N.T. Butterfield & Son Ltd. Earnings Growth & NTB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and a decrease next year of $0.08 per share.
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.05 per share, and an increase next year of $4.83 per share.
The Bank of N.T. Butterfield & Son Ltd. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||